Analytik Jena appoints new managing director at Japanese subsidiary
Analytik Jena AG has appointed Dr. Marco Tilgner as the new managing director of the Japanese subsidiary AJ Japan as of January 1, 2014. Mr. Tilgner, who will report in his future role to Analytik Jena Chief Executive Officer Klaus Berka, already took over responsibility for finance and administration at the subsidiary two months ago as its CFO as part of comprehensive restructuring measures.
"Marco Tilgner has international experience in the areas of finance and business management. He has also worked in Asia over many years and especially developed firm roots in Japan. His primary task will now be to implement the restructuring measures that are needed at our Japanese subsidiary in a consistent manner and to position AJ Japan effectively," said Klaus Berka.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Generation of human brain organoids with the ability to learn - Bioengineered Neuronal Organoids recapitulate important morphological features of the human brain
Stem Cells from Placenta Show Promise for Treating Heart Failure
Amorfix announces leading sensitivity for prion detection in spiked human blood samples

The 7th BioProScale Symposium took place again as in-person event in Berlin - New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering
Emerging gene editing approach seeks broad spectrum crop disease resistance

New Start-up develops aquafarms for macroalgae - AWI and Carbonwave spin-off: Large algae simultaneously bind CO₂ and create raw materials for the chemical industry
Variants in 3 genes account for most dog coat differences - Method for pinpointing gene combinations useful for studies of human disease

Lab-grown canine skin provides a canvas for testing medical treatments - Eliminating the need for animal testing
Data analysis looks at Zika’s introduction to Americas, predicts microcephaly cases

Analytica 2022: Analytics that benefit consumer and environmental protection - Does your mineral water contain nanoplastics or other pollutants?
